（3β，6α，12β）-3，12- 二羟基二氮杂-24烯6,20二基双-β-<SC>D</SC>吡喃葡萄糖苷

产品名称：

22427-39-0
Ginsenoside Rg1
Panaxoside Rg1
Sanchinoside Rg1
Panaxoside A
Sanchinoside C1
Ginsenoside g1
Ginsenoside A2
(3β,6α,12β)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-β-D-glucopyranoside
人参皂苷Rg1
（3β，6α，12β）-3，12- 二羟基二氮杂-24烯6,20二基双-β-D吡喃葡萄糖苷

产品介绍：

产品说明

一般描述

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

分析说明

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

其他说明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

基本信息

经验(实验)分子式	C₄₂H₇₂O₁₄
分子量	801.01
MDL编号	MFCD00210293

产品性质

等级	certified reference material pharmaceutical secondary standard
描述	Pharmaceutical Secondary Standard; Certified Reference Material
包装	pkg of 50 mg
格式	neat
药典可追溯性	traceable to USP 1291672
储存温度	2-8℃
SMILES string	C\C(C)=C/CC[C@](C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H]2CC[C@]3(C)[C@@H]2[C@H](O)C[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5[C@H](C[C@@]34C)O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O
InChI	1S/C42H72O14/c1-20(2)10-9-13-42(8,56-37-34(52)32(50)30(48)25(19-44)55-37)21-11-15-40(6)28(21)22(45)16-26-39(5)14-12-27(46)38(3,4)35(39)23(17-41(26,40)7)53-36-33(51)31(49)29(47)24(18-43)54-36/h10,21-37,43-52H,9,11-19H2,1-8H3/t21-,22+,23-,24+,25+,26+,27-,28-,29+,30+,31-,32-,33+,34+,35-,36+,37-,39+,40+,41+,42-/m0/s1
InChI key	YURJSTAIMNSZAE-HHNZYBFYSA-N

安全信息

象形图
警示用语：	Warning
危险声明	H302
预防措施声明	P264 - P270 - P301 + P312 + P330 - P501
危险分类	Acute Tox. 4 Oral
储存分类代码	13 - Non Combustible Solids
WGK	WGK 3
闪点(F)	Not applicable
闪点(C)	Not applicable